Clinical Study on the Use of Artificial Liver Supporting System in the Treatment of Acute or Chronic Liver Failure
ZHOU Xinmin,HAN Ying,LIU Jun,YANG Yan,SONG Hange,JIN Yan,FENG Xiangying,HUI Na,WANG Meixia,LIU Wei,MIAO Jiyan,WU Kaichun,DING Jie,FAN Daiming
DOI: https://doi.org/10.3969/j.issn.1008-7125.2007.12.008
2007-01-01
Abstract:Background:Currently,there is no effective treatment for hepatic failure,unless liver transplantation is performed timely.Otherwise,the patient needs long term hospitalization and the mortality will be still high.The auxiliary artificial liver support systems have already been used clinically in the treatment of acute and chronic liver failure.Aims:Use plasma exchange(PE)and molecular adsorbent recirculating system(MARS)to treat patients with liver failure caused by various diseases and to explore the effect of these two non-biological artificial liver supporting systems in the treatment of acute and chronic liver failure.Methods:On the basis of routine medical treatment,148 patients with liver failure were divided into two groups,60 patients were treated with PE and 88 patients were treated with MARS.Alterations in liver and renal function,blood ammonia,blood coagulating parameters,electrolytes and blood routine were observed before and after treatment,and the effects on clinical outcome and survival rate were evaluated.Results:After 1-3 months follow-up,the survival rates of these two groups were 55.0% and 64.8%,respectively.MARS was slightly better than PE,but the difference was not statistically significant.Both PE and MARS could decrease significantly the serum levels of total bilirubin,alanine aminotransferase,aspartate aminotransferase and ammonia.No obvious changes were observed in serum levels of total protein,renal function,electrolytes,blood routine and blood gas analysis.Prothrombin activity increased and prothrombin time decreased in both groups 72 hours after treatment.Adverse effect rate was higher in PE than in MARS group,such as tremor,short of breath,nausea and vomiting.Conclusions:Both PE and MARS are safe and effective auxiliary methods in the treatment of liver failure,especially for those liver failure patients caused by non-viral diseases.